Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Insulin human zinc [USP]
RN: 8049-62-5

Note

  • An insulin, zinc chloride preparation in the form of a suspension of crystals and amorphous material in a ratio of approximately 7:3. Typically, lente insulin has a duration of activity that lasts between 13-20 hours after dosage.

Molecular Formula

  • Unspecified
 

Classification Codes

  • Antidiabetic
  • Drug / Therapeutic Agent
  • Human Data
  • Hypoglycemic Agents
  • Reproductive Effect
  • Tumor Data
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Insulin human zinc [USP]
  • Insulin zinc injection (aqueous suspension) [JAN]
  • Insulin zinc purified porcine (suspension) [JAN]
  • Insulin zinc suspension, compound [INN]
  • Insulin zinc [USP:BAN]
  • Insulin, lente

MeSH Heading

  • Insulin, lente

Synonyms

  • Caninsulin
  • EINECS 232-469-4
  • Extended zinc insulin suspension
  • Iletin U 40
  • Iniectabile insulini zinci amorphi
  • Iniectabile insulini zinci compositum
  • Iniectabile insulini zinci cristallisati
  • Injectio insulini cum zinco neutralis
  • Insulin human zinc
  • Insulin lente
  • Insulin lente MC
  • Insulin novo lente
  • Insulin NPH
  • Insulin semilente
  • Insulin zinc
  • Insulin zinc complex
  • Insulin zinc injection (aqueous suspension)
  • Insulin zinc purified porcine (suspension)
  • Insulin zinc suspension
  • Insulin zinc suspension, compound
  • Insulin, crystalline
  • Insulin, crystalline zinc
  • Insulin, isophane
  • insulin, semi-Lente
  • Insulin, ultralente
  • Insulina-zinco sospensione (amorfa)
  • Insulina-zinco sospensione (amorfa) [DCIT]
  • Insulina-zinco sospensione (crisstallina)
  • Insulina-zinco sospensione (crisstallina) [DCIT]
  • Insulina-zinco sospensione composta
  • Insulina-zinco sospensione composta [DCIT]
  • Insulini cum zinco (amorphi) suspensio
  • Insulini cum zinco (amorphi) suspensio [INN-Latin]
  • Insulini cum zinco (crystallisati)
  • Insulini cum zinco (crystallisati) [INN-Latin]
  • Insulini cum zinco suspensio compositacompound
  • Insulini cum zinco suspensio compositacompound [INN-Latin]
  • Insulini zinci amorphi suspensio
  • Insulini zinci cristallisati suspensio
  • Insulini zinci suspensio mixta
  • Insulini zinco amorphi aquosuspensa
  • Insulini zinco cristallisati aquosuspensa
  • IZSAB
  • Lente
  • Lente Iletin
  • Lente insulin
  • Monotard
  • Novolin U
  • NPH
  • NPH Iletin
  • NPH insulin
  • Prompt insulin zinc suspension
  • Semilente insulin
  • Suspensio zinc-insulini
  • Suspension d'insuline zinc (amorphe)
  • Suspension d'insuline zinc (amorphe) [INN-French]
  • Suspension d'insuline zinc (composee)
  • Suspension d'insuline zinc (composee) [INN-French]
  • Suspension d'insuline zinc (cristallisee)
  • Suspension d'insuline zinc (cristallisee) [INN-French]
  • Suspension de insulina cinc (amorfa)
  • Suspension de insulina cinc (amorfa) [INN-Spanish]
  • Suspension de insulina cinc (compuesta)
  • Suspension de insulina cinc (compuesta) [INN-Spanish]
  • Suspension de insulina cinc (cristal.)
  • Suspension de insulina cinc (cristal.) [INN-Spanish]
  • Suspension injectable d'insuline zinc amorphe
  • Suspension injectable d'insuline zinc cristallisee
  • Suspension injectable d'insuline zinc mixte
  • Ultra lente iszilin
  • Ultralenta zinc insulin
  • Ultralente insulin
  • Zinc insulin
  • Zinc-insulinum

Systematic Name

  • Insulin zinc

Registry Numbers

CAS Registry Number

  • 8049-62-5

Other Registry Numbers

  • 9004-16-4
  • 9048-96-8
  • 99551-09-4

System Generated Number

  • 0008049625

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LDLo subcutaneous 37mg/kg (37mg/kg)   Drugs in Japan Vol. 6, Pg. 84, 1982.
rabbit LDLo subcutaneous 75mg/kg (75mg/kg)   Drugs in Japan Vol. 6, Pg. 84, 1982.